Select Page

This report studies the global market size of Insulin Injection Pen in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insulin Injection Pen in these regions. This research report categorizes the global Insulin Injection Pen market by top players/brands, region, type and end user. This report also studies the global Insulin Injection Pen market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The global Insulin Injection Pen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Insulin Injection Pen market based on company, product type, end user and key regions. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Novo Nordisk A/S Eli Lilly and Company AstraZeneca plc Biocon Ltd. Sanofi S.A. Becton, Dickinson and Company F. Hoffman-La Roche Owen Mumford Ltd Jiangsu Delfu Co., Ltd. Wockhardt Ltd. Market size by Product Reusable Pens Disposable Pens Market size by End User Hospital Diabetes Clinics/ Centers Home Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Insulin Injection Pen market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.

Get sample copy of the report:
www.marketdensity.com/contact?ref=Sample&reportid=85097

Table of Contents:
Table of Contents

1 Study Coverage
1.1 Insulin Injection Pen Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Insulin Injection Pen Market Size Growth Rate by Product
1.4.2 Reusable Pens
1.4.3 Disposable Pens
1.5 Market by End User
1.5.1 Global Insulin Injection Pen Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Diabetes Clinics/ Centers
1.5.4 Home
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Insulin Injection Pen Market Size
2.1.1 Global Insulin Injection Pen Revenue 2013-2025
2.1.2 Global Insulin Injection Pen Sales 2013-2025
2.2 Insulin Injection Pen Growth Rate by Regions
2.2.1 Global Insulin Injection Pen Sales by Regions
2.2.2 Global Insulin Injection Pen Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Insulin Injection Pen Sales by Manufacturers
3.1.1 Insulin Injection Pen Sales by Manufacturers
3.1.2 Insulin Injection Pen Sales Market Share by Manufacturers
3.1.3 Global Insulin Injection Pen Market Concentration Ratio (CR5 and HHI)
3.2 Insulin Injection Pen Revenue by Manufacturers
3.2.1 Insulin Injection Pen Revenue by Manufacturers (2013-2018)
3.2.2 Insulin Injection Pen Revenue Share by Manufacturers (2013-2018)
3.3 Insulin Injection Pen Price by Manufacturers
3.4 Insulin Injection Pen Manufacturing Base Distribution, Product Types
3.4.1 Insulin Injection Pen Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insulin Injection Pen Product Type
3.4.3 Date of International Manufacturers Enter into Insulin Injection Pen Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Insulin Injection Pen Sales by Product
4.2 Global Insulin Injection Pen Revenue by Product
4.3 Insulin Injection Pen Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Insulin Injection Pen Breakdown Data by End User

6 North America
6.1 North America Insulin Injection Pen by Countries
6.1.1 North America Insulin Injection Pen Sales by Countries
6.1.2 North America Insulin Injection Pen Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Insulin Injection Pen by Product
6.3 North America Insulin Injection Pen by End User

7 Europe
7.1 Europe Insulin Injection Pen by Countries
7.1.1 Europe Insulin Injection Pen Sales by Countries
7.1.2 Europe Insulin Injection Pen Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Insulin Injection Pen by Product
7.3 Europe Insulin Injection Pen by End User

8 Asia Pacific
8.1 Asia Pacific Insulin Injection Pen by Countries
8.1.1 Asia Pacific Insulin Injection Pen Sales by Countries
8.1.2 Asia Pacific Insulin Injection Pen Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Insulin Injection Pen by Product
8.3 Asia Pacific Insulin Injection Pen by End User

9 Central & South America
9.1 Central & South America Insulin Injection Pen by Countries
9.1.1 Central & South America Insulin Injection Pen Sales by Countries
9.1.2 Central & South America Insulin Injection Pen Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Insulin Injection Pen by Product
9.3 Central & South America Insulin Injection Pen by End User

10 Middle East and Africa
10.1 Middle East and Africa Insulin Injection Pen by Countries
10.1.1 Middle East and Africa Insulin Injection Pen Sales by Countries
10.1.2 Middle East and Africa Insulin Injection Pen Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Insulin Injection Pen by Product
10.3 Middle East and Africa Insulin Injection Pen by End User

11 Company Profiles
11.1 Novo Nordisk A/S
11.1.1 Novo Nordisk A/S Company Details
11.1.2 Company Business Overview
11.1.3 Novo Nordisk A/S Insulin Injection Pen Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Novo Nordisk A/S Insulin Injection Pen Products Offered
11.1.5 Novo Nordisk A/S Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Company Business Overview
11.2.3 Eli Lilly and Company Insulin Injection Pen Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Eli Lilly and Company Insulin Injection Pen Products Offered
11.2.5 Eli Lilly and Company Recent Development
11.3 AstraZeneca plc
11.3.1 AstraZeneca plc Company Details
11.3.2 Company Business Overview
11.3.AstraZeneca plc Insulin Injection Pen Sales, Revenue and Gross Margin (2013-2018)
11.3.4 AstraZeneca plc Insulin Injection Pen Products Offered
11.3.5 AstraZeneca plc Recent Development
11.4 Biocon Ltd.
11.4.1 Biocon Ltd. Company Details
11.4.2 Company Business Overview
11.4.3 Biocon Ltd. Insulin Injection Pen Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Biocon Ltd. Insulin Injection Pen Products Offered
11.4.5 Biocon Ltd. Recent Development
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Details
11.5.2 Company Business Overview
11.5.3 Sanofi S.A. Insulin Injection Pen Sales, Revenue and Gross Margin (2013-2018)
11.5.4 Sanofi S.A. Insulin Injection Pen Products Offered
11.5.5 Sanofi S.A. Recent Development
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Details
11.6.2 Company Business Overview
11.6.3 Becton, Dickinson and Company Insulin Injection Pen Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Becton, Dickinson and Company Insulin Injection Pen Products Offered
11.6.5 Becton, Dickinson and Company Recent Development
11.7 F. Hoffman-La Roche
11.7.1 F. Hoffman-La Roche Company Details
11.7.2 Company Business Overview
11.7.3 F. Hoffman-La Roche Insulin Injection Pen Sales, Revenue and Gross Margin (2013-2018)
11.7.4 F. Hoffman-La Roche Insulin Injection Pen Products Offered
11.7.5 F. Hoffman-La Roche Recent Development
11.8 Owen Mumford Ltd
11.8.1 Owen Mumford Ltd Company Details
11.8.2 Company Business Overview
11.8.3 Owen Mumford Ltd Insulin Injection Pen Sales, Revenue and Gross Margin (2013-2018)
11.8.4 Owen Mumford Ltd Insulin Injection Pen Products Offered
11.8.5 Owen Mumford Ltd Recent Development
11.9 Jiangsu Delfu Co., Ltd.
11.9.1 Jiangsu Delfu Co., Ltd. Company Details
11.9.2 Company Business Overview
11.9.3 Jiangsu Delfu Co., Ltd. Insulin Injection Pen Sales, Revenue and Gross Margin (2013-2018)
11.9.4 Jiangsu Delfu Co., Ltd. Insulin Injection Pen Products Offered
11.9.5 Jiangsu Delfu Co., Ltd. Recent Development
11.10 Wockhardt Ltd.
11.10.1 Wockhardt Ltd. Company Details
11.10.2 Company Business Overview
11.10.3 Wockhardt Ltd. Insulin Injection Pen Sales, Revenue and Gross Margin (2013-2018)
11.10.4 Wockhardt Ltd. Insulin Injection Pen Products Offered
11.10.5 Wockhardt Ltd. Recent Development

12 Future Forecast
12.1 Insulin Injection Pen Market Forecast by Regions
12.1.1 Global Insulin Injection Pen Sales Forecast by Regions 2018-2025
12.1.2 Global Insulin Injection Pen Revenue Forecast by Regions 2018-2025
12.2 Insulin Injection Pen Market Forecast by Product
12.2.1 Global Insulin Injection Pen Sales Forecast by Product 2018-2025
12.2.2 Global Insulin Injection Pen Revenue Forecast by Product 2018-2025
12.3 Insulin Injection Pen Market Forecast by End User
12.4 North America Insulin Injection Pen Forecast
12.5 Europe Insulin Injection Pen Forecast
12.6 Asia Pacific Insulin Injection Pen Forecast
12.7 Central & South America Insulin Injection Pen Forecast
12.8 Middle East and Africa Insulin Injection Pen Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Insulin Injection Pen Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Buy this report online:
www.marketdensity.com/global-insulin-injection-pen-market-insights-forecast